Used in the development of therapeutic treatments for inflammatory bowel diseases such as ulcerative colitis and Crohn’s disease. Targets integrin β7 to block lymphocyte migration into gut tissues, reducing inflammation. Investigated for its role in modulating immune responses in autoimmune conditions by inhibiting specific T-cell trafficking. Supports research in biologics aimed at selective immunosuppression with potentially fewer systemic side effects.